Drugs / adrenocorticotropic hormone
adrenocorticotropic hormone
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT02931175 | Nov 2017 → Apr 2020 | uveitis | Quan Dong Nguyen | Completed | No outcome recorded |
Evidence & citations 6 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | adrenocorticotropic hormone | “H.P. Acthar Gel is a highly purified sterile preparation of the adrenocorticotropic hormone (ACTH) gelatin to provide a prolonged release after intramuscular or subcutaneous...” NCT02931175 ↗ |
| Known as | ACTH | ClinicalTrials.gov intervention name — accepted as the source's own label NCT02931175 ↗ |
| Known as | ACTH gel | “Mandatory twice a week (Mondays and Thursdays) treatment with SC ACTH gel 80 U/day starting at BL until month 6.” NCT02931175 ↗ |
| Known as | H.P. Acthar Gel | “H.P. Acthar Gel is a highly purified sterile preparation of the adrenocorticotropic hormone (ACTH) gelatin to provide a prolonged release after intramuscular or subcutaneous...” NCT02931175 ↗ |
| Action | Activate | “A very well-known anti-inflammatory mechanism of action of ACTH is the production glucocorticoids by stimulating the adrenal glands.” NCT02931175 ↗ |
| Route | Subcutaneous | “repeated SC injections of ACTH gel” NCT02931175 ↗ |